Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity
Plasmodium vivax is the most widespread and difficult to treat cause of human malaria. The development of vaccines against the blood stages of P. vivax remains a key objective for the control and elimination of vivax malaria. Erythrocyte binding-like (EBL) protein family members such as Duffy bindin...
Auteurs principaux: | Han, J-H, Cho, J-S, Ong, JJY, Park, J-H, Nyunt, MH, Sutanto, E, Trimarsanto, H, Petros, B, Aseffa, A, Getachew, S, Sriprawat, K, Anstey, NM, Grigg, MJ, Barber, BE, William, T, Qi, G, Liu, Y, Pearson, RD, Auburn, S, Price, RN, Nosten, F, Rénia, L, Russell, B, Han, E-T |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Public Library of Science
2020
|
Documents similaires
-
Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity.
par: Jin-Hee Han, et autres
Publié: (2020-07-01) -
Genomic analysis of plasmodium vivax in southern Ethiopia reveals selective pressures in multiple parasite mechanisms
par: Auburn, S, et autres
Publié: (2019) -
Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics
par: Auburn, S, et autres
Publié: (2018) -
Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
par: Park, J-H, et autres
Publié: (2022) -
Genomic analysis of Plasmodium vivax describes patterns of connectivity and putative drivers of adaptation in Ethiopia
par: Kebede, AM, et autres
Publié: (2023)